(Q24314621)

GOA release 2020-03-11

zinc ion binding

1 reference

Journal of Thrombosis and Haemostasis

GOA release 2020-03-11

1 reference

R A Pixley

1

0 references

Y Lin

series ordinal

2

0 references

I Isordia-Salas

series ordinal

3

0 references

R W Colman

series ordinal

4

0 references

language of work or name

English

0 references

publication date

August 2003

0 references

published in

0 references

volume

1

0 references

issue

8

0 references

page(s)

1791-8

0 references

cites work

Kininogens are antithrombotic proteins In vivo

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc‐dependent binding to an anionic surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

Surface plasmon resonance detection and multispot sensing for direct monitoring of interactions involving low-molecular-weight analytes and for determination of low affinities

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

Cloning, expression and characterization of human kininogen domain 3

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

Conformation of high molecular weight kininogen: effects of kallikrein and factor XIa cleavage

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

Parallel mechanisms of high molecular weight kininogen action as a cofactor in kallikrein inactivation and prekallikrein activation reactions

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

Binding of heparin to human high molecular weight kininogen

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

Kinetic analysis of the role of zinc in the interaction of domain 5 of high-molecular weight kininogen (HK) with heparin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

Modelling in peptide design

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

Activation of the plasma kallikrein/kinin system on endothelial cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

Thrombin-induced platelet aggregation is inhibited by the heptapeptide Leu271-Ala277 of domain 3 in the heavy chain of high molecular weight kininogen

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

Zinc as a cofactor for heparin neutralization by histidine-rich glycoprotein

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

Heparin-induced self-association of fibroblast growth factor-2. Evidence for two oligomerization processes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

FGF2-Heparin co-crystal complex-assisted design of mutants FGF1 and FGF7 with predictable heparin affinities

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

Inhibition of cell adhesion by high molecular weight kininogen

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

Studies on Human High Molecular Weight (HMW) Kininogen. II. Structural Change of HMW Kininogen by the Action of Human Plasma Kallikrein1

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

High molecular weight kininogen binds to unstimulated platelets

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021

Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00291.X

7 January 2021